The European Parliament has voted through reforms to legislation regulating the pharma sector, which the industry claims could compromise competitiveness and patient care.The new directive and regulation – which were endorsed by thumping majorities – include a wide range, headed by a reduction in the minimum regulatory data protection (RDP) period for new medicines. That […]